T

Titan Pharmaceuticals
D

TTNP

3.90000
USD
0.40
(11.43%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
3,565,513
أصول ذات صلة
E
ETON
0.534
(4.19%)
13.280 USD
المزيد
الأخبار المقالات

العنوان: Titan Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.